Original news and analysis on international IP policy
Seeking to address the growing issue of cancer, and in particular the lack of access to diagnosis and treatment in low and middle-income countries, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Atomic Energy Agency (IAEA) have entered into a collaboration.
Efforts to reclaim rights under the US Copyright Act have increased recently as the window of opportunity for works created in the mid-20th century opens. In comparative cases, Paul McCartney's decision to take back copyright assignments of his music in the United States appears to have been the right choice but may hang on a questionable UK ruling denying the same request by members of rock group Duran Duran, several intellectual property lawyers said.
Health advocacy groups called on the European Commission yesterday to change the way it funds research and development for new medicines so that innovations can serve a larger public.
An interesting year lies ahead for trade policymakers. With US President Donald Trump sticking to his “America First” announcement pulling back from the Trans-Pacific Partnership right away, a new trade (world) order might be in the making. In every crisis, there is opportunity, Argentinian Trade Minister Susana Malcora said in Davos during the January World Economic Forum (WEF) where the business elite otherwise traded concerns at the beginning of an unpredictable year 2017.
The European Parliament Legal Committee this week did not bother to further discuss the ratification of the Marrakesh Treaty on copyright exceptions for print disabled persons. Instead, Rapporteur Max Andersson declared that he favoured putting the file to a vote right away. Andersson told Intellectual Property Watch that the parliament would adopt the report in March or latest April.
The World Health Organization and The Netherlands government will co-host a meeting in the spring that brings experts together to look at high drug prices and the purchasing of medicines.
Copyright, copyright and more copyright tops Europe's intellectual property agenda for 2017. With the EU institutions mulling major reforms to copyright laws, publishers are pushing for a right to bar unauthorised copying or reuse of their content for commercial purposes, audiovisual authors for fair remuneration for use of their works on platforms like YouTube. The European Commission will begin reviewing the enforcement of IP rights as well as delving further into issues related to liability of platforms for infringement. But there are many patent issues too, including plant variety protection, patent incentives, and the ongoing unitary patent court.
Just a day after US President Donald Trump withdrew the United States from the Trans-Pacific Partnership, the International Trade Committee of the European Parliament passed a recommendation in favour of adopting the Comprehensive Economic and Trade Agreement (CETA) between Canada and the EU. Meanwhile, the EU Trade Commissioner said trade is not to blame and the EU will negotiate many trade deals this year.
Nearly two dozen top biopharmaceutical companies have launched a global initiative intended to increase access to prevention and care of non-transmitted diseases in low and lower-middle income countries.
Artificial intelligence has succeeded the Internet of Things or the earlier cloud mania as buzzword number one at the Annual Meeting of the World Economic Forum that started today (17 January) in Davos, Switzerland. While ethical questions surrounding the intelligent machines are discussed at length and the question for regulatory steps considered, answers of who will own the knowledge created by machines or intelligent bots vary.